Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study

Re-exposures to culprit medications occurred in almost half of the adverse drug events diagnosed in emergency departments. Many of these were appropriate re-exposures to essential medications for indications in which the risk of uncontrolled disease likely outweighed the risk of a repeat adverse event. More research is needed to understand re-exposures to nonessential medications or medications with safer alternatives.

Authors

Institutions

Publication Details

Journal
Pharmacoepidemiology and Drug Safety
Published
2024-09-01
DOI
https://doi.org/10.1002/pds.70012
Citations
5
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
1.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study

Maeve E. Wickham, Amber Cragg, Corinne M. Hohl, Michael R. Law et al.
5 citations
Pharmacoepidemiology and Drug Safety
Pharmaceutical Practices and Patient Outcomes
1.72
article

Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study

Maeve E. Wickham, Amber Cragg, Corinne M. Hohl, Michael R. Law, Kimberlyn McGrail
article en
5 citations

Abstract

Re-exposures to culprit medications occurred in almost half of the adverse drug events diagnosed in emergency departments. Many of these were appropriate re-exposures to essential medications for indications in which the risk of uncontrolled disease likely outweighed the risk of a repeat adverse event. More research is needed to understand re-exposures to nonessential medications or medications with safer alternatives.

Pharmacoepidemiology and Drug SafetyVol. 33(9)
University of British Columbia (CA), Vancouver General Hospital (CA)
Canadian Institutes of Health Research
Good health and well-being
Openalex Percentile: Top 16%
Pharmaceutical Practices and Patient Outcomes
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.